Health ❯ Oncology

Lung Cancer

Non-Small Cell Lung Cancer Treatment Options Melanoma Treatment Outcomes Genetic Mutations Cell Biology Psychosocial Factors Tumor Treatment Treatment Strategies Skin Cancer Small Cell Lung Cancer Tumor Progression Early Detection Diagnosis Drug Development EGFR Mutations HER2-Mutant Lung Cancer Risk Factors Solid Tumors Malignant Pulmonary Tumor Early-Stage Lung Cancer Early-Stage Primary Lung Cancer

3 ARTICLES

2w ago

Foghorn Therapeutics Ends Lilly Partnership, Stops SMARCA2 Program and Cuts 40% of Staff

Because the Phase 1 candidate engaged its target but failed to show clinical benefit, the company will shift to proprietary programs to stretch cash into the second half of 2029.

4 ARTICLES

4w ago

Rare Inherited EGFR T790M Variant Dramatically Raises Lung Cancer Risk

9 ARTICLES

last mo.

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

3 ARTICLES

2mo ago

Enhertu Improves Progression‑Free Survival in Phase 3 HER2‑Mutant Lung Cancer Trial

5 ARTICLES

3mo ago

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

4 ARTICLES

3mo ago

Pfizer Lung Cancer Drug Fails to Improve Survival in Late‑Stage Trial

7 ARTICLES

4mo ago

Researchers Find 14‑Protein Blood Signature That Predicts Lung Cancer Years Ahead

3 ARTICLES

8mo ago

Lung Tumors Tap Nerve–Brain Circuit to Thwart Immunity, Mouse Study Finds

5 ARTICLES

8mo ago

Bristol Myers to Use Microsoft’s Imaging Network to Deploy FDA-Cleared AI for Earlier Lung Cancer Detection

5 ARTICLES

11mo ago

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

5 ARTICLES

11mo ago

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

29 ARTICLES

11mo ago

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

3 ARTICLES

last yr.

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2